Statement Also Supports Use of AlloSure Heart and AlloMap Heart   BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the issuance of a new position statement by the American Society of … [Read more…]

The Company’s Proprietary Address, Navigate, Design (AND)™ Platform Produces Medicines that are Better, Safer and More Tolerable for Patients After Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating … [Read more…]

Increased focus on product development aims to support health plans to better integrate genomics into member benefits ST. PETERSBURG, Fla.–(BUSINESS WIRE)–InformedDNA®, the nation’s leading applied genomics solutions company, today announced it is building on their foundation in genomics care delivery and benefits management expertise to launch a new set of scalable solutions to enable wider … [Read more…]

— Partnership will further validate Exscientia’s functional drug testing platform to predict response in haematological cancers — OXFORD, England & BERLIN, Germany–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Charité – Universitätsmedizin Berlin (Charité) to utilise Exscientia’s AI-driven precision medicine platform in haematological cancers. Under the collaboration, Charité will evaluate the potential … [Read more…]

– SER-109 Biologics License Application (BLA) under review with U.S. Food and Drug Administration (FDA) with target action date of April 26, 2023 under Prescription Drug User Fee Act (PDUFA) – – Anticipate SER-109 commercial launch soon after potential FDA approval decision – – SER-155 Phase 1b study cohort 2 enrollment ongoing; anticipate reporting initial … [Read more…]

IRVING, Texas–(BUSINESS WIRE)–Yesterday on Capitol Hill, Vizient, Inc. hosted a policy briefing titled, “Provider Pressures Persist: Hospitals’ Struggles Against Financial, Workforce and Supply Chain Strains” at the Rayburn House Office Building in Washington, D.C. Attended by more than 50 Congressional staff and other healthcare stakeholders, this briefing focused on how hospitals are responding to mounting … [Read more…]

Company expands leadership team to further accelerate market growth NEW YORK–(BUSINESS WIRE)–Nomad Health, the leading digital marketplace for temporary healthcare jobs, announced that Anne Walker has joined the company as its new chief financial officer (CFO). Responsible for managing Nomad Health’s financial strategy as it continues modernizing the healthcare staffing industry, Walker has over 20 … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Postmenopausal Osteoporosis – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Postmenopausal osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Plasmid DNA Contract Manufacturing Market Size, Share & Trends Analysis Report By Application (Cell & Gene Therapy, Immunotherapy), By Therapeutic Area (Cancer, Infectious Diseases), By End-user, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global plasmid DNA contract manufacturing market size is expected to reach … [Read more…]